Vencorex presents its long term strategic ambition. This strategy is based on focusing its activities toward specialty isocyanates. (HDI, IPDI, derivatives and new products).
Vencorex objective is to strengthen its worldwide position in Aliphatic Isocyanates business. (HDI, IPDI, Tolonate & Easaqua grades and new products).
To achieve this long term ambition, Vencorex plans to enhance its footprint on production capabilities, commercial activities and R&D innovation towards the following configuration.
Tolonate production facilities in 3 main continents ready to serve global market. Vencorex already has these at Pont De Claix, France and Freeport, TX USA, with an additional facility being implemented in Thailand, starting in 2015.
With all these initiatives, Vencorex will therefore implement several industrial projects with the objective to sustain its position as among the leading global partners for specialty isocyanates in the coming years.
Vencorex strategic ambition is supported by both shareholders: PTTGC and Perstorp.
本站所有信息與內容，版權歸原作者所有。網站中部分新聞、文章來源于網絡或會員供稿，如讀者對作品版權有疑議，請及時與我們聯系，電話：025-85303363 QQ：2402955403。文章僅代表作者本人的觀點，與本網站立場無關。轉載本站的內容，請務必注明"來源：林中祥膠粘劑技術信息網（www.www.cnmindian.com）".
©2015 南京愛德福信息科技有限公司 蘇ICP備10201337 | 技術支持：南京聯眾網絡科技有限公司
加載中...
<rt id="ieuyu"></rt>